{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:42:39Z","timestamp":1790145759611,"version":"4.0.1"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T00:00:00Z","timestamp":1510617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical Research Council (GB)","award":["G0300400"],"award-info":[{"award-number":["G0300400"]}]},{"name":"Medical Research Council (GB)","award":["G1001190"],"award-info":[{"award-number":["G1001190"]}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["108065\/Z\/15\/Z"],"award-info":[{"award-number":["108065\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_12023\/26"],"award-info":[{"award-number":["MC_UU_12023\/26"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1002432","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T18:25:11Z","timestamp":1510683911000},"page":"e1002432","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2082-0861","authenticated-orcid":true,"given":"Alexander J.","family":"Szubert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Prendergast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moira J.","family":"Spyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Musiime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1875-202X","authenticated-orcid":true,"given":"Philippa","family":"Musoke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutsa","family":"Bwakura-Dangarembizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Nahirya-Ntege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3590-0140","authenticated-orcid":true,"given":"Margaret J.","family":"Thomason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Ndashimye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immaculate","family":"Nkanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Senfuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0291-8590","authenticated-orcid":true,"given":"Boniface","family":"Mudenge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3925-9258","authenticated-orcid":true,"given":"Nigel","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9738-5490","authenticated-orcid":true,"given":"Diana M.","family":"Gibb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0412-8509","authenticated-orcid":true,"given":"A. Sarah","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the ARROW Trial Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,11,14]]},"reference":[{"key":"ref1","unstructured":"Joint United Nations Programme on HIV\/AIDS. 90-90-90: an ambitious treatment target to help end the AIDS epidemic. Geneva: 2014."},{"key":"ref2","unstructured":"Joint United Nations Programme on HIV\/AIDS. AIDS by the numbers. 2016. http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/AIDS-by-the-numbers-2016_en.pdf<\/ext-link>."},{"key":"ref3","unstructured":"World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach. 2016. http:\/\/apps.who.int\/iris\/bitstream\/10665\/208825\/1\/9789241549684_eng.pdf<\/ext-link>."},{"key":"ref4","unstructured":"Joint United Nations Programme on HIV\/AIDS. Diagnostics access initiative to achieve the 90-90-90 treatment target. 2015. http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/20150422_diagnostics_access_initiative.pdf<\/ext-link>."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1473-3099(11)70141-4","article-title":"HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review","volume":"11","author":"KCE Sigaloff","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"ref6","unstructured":"World Health Organization. WHO HIV drug resistance report 2012. Geneva: 2012."},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1056\/NEJMoa1311274","article-title":"Assessment of Second-Line Antiretroviral Regimens for HIV Therapy in Africa","volume":"371","author":"NI Paton","year":"2014","journal-title":"N Engl J Med"},{"issue":"9875","key":"ref8","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0140-6736(12)62198-9","article-title":"Routine vs clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial","volume":"381","year":"2013","journal-title":"Lancet"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/QAD.0000000000001116","article-title":"Once- versus twice-daily abacavir and lamivudine in African children: the randomised controlled ARROW Trial","volume":"30","author":"V Musiime","year":"2016","journal-title":"AIDS"},{"key":"ref10","unstructured":"World Health Organization. Antiretroviral therapy for HIV infection in infants and children: Towards universal access. Recommendations for a public health approach. 2006. http:\/\/www.who.int\/hiv\/pub\/guidelines\/paediatric020907.pdf<\/ext-link>."},{"issue":"1","key":"ref11","first-page":"6","article-title":"Update of the drug resistance mutations in HIV-1: March 2013","volume":"21","author":"VA Johnson","year":"2013","journal-title":"Top Antivir Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000331998","article-title":"The HIVdb System for HIV-1 Genotypic Resistance Interpretation","volume":"55","author":"MW Tang","year":"2012","journal-title":"Intervirology"},{"key":"ref13","unstructured":"World Health Organization. Antiretroviral therapy for HIV infection in infants and children: Towards universal access. Recommendations for a public health approach. 2010. http:\/\/www.who.int\/hiv\/pub\/guidelines\/paediatric020907.pdf<\/ext-link>."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"660","DOI":"10.2471\/BLT.07.043497","article-title":"Development of a WHO growth reference for school-aged children and adolescents","volume":"85","author":"M De Onis","year":"2007","journal-title":"Bull World Health Organ"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/sim.4780132207","article-title":"Age-related reference ranges: significance tests for models and confidence intervals for centiles","volume":"13","author":"A Wade","year":"1994","journal-title":"Stat Med"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/QAI.0b013e31827b4ac8","article-title":"Long-Term Virologic Response and Genotypic Resistance Mutations in HIV-1 Infected Kenyan Children on Combination Antiretroviral Therapy","volume":"62","author":"DC Wamalwa","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S1473-3099(08)70180-4","article-title":"Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa","volume":"8","author":"CG Sutcliffe","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1086\/648079","article-title":"Effectiveness of Pediatric Antiretroviral Therapy in Resource-Limited Settings: A Systematic Review and Meta-analysis","volume":"49","author":"AL Ciaranello","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/jama.1995.03530070052029","article-title":"Natural history of HIV-1 cell-free viremia","volume":"274","author":"DL Henrard","year":"1995","journal-title":"JAMA"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.4049\/jimmunol.165.3.1692","article-title":"Dynamics of HIV-Specific CD8+<\/sup> T Lymphocytes with Changes in Viral Load","volume":"165","author":"L Mollet","year":"2000","journal-title":"J Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/354453a0","article-title":"Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition","volume":"354","author":"RE Phillips","year":"1991","journal-title":"Nature"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/QAI.0000000000000671","article-title":"HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds","volume":"70","author":"L Harrison","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/QAI.0b013e3182060610","article-title":"Virologic Failure and Second-Line Antiretroviral Therapy in Children in South Africa\u2014The IeDEA Southern Africa Collaboration","volume":"56","author":"M-A Davies","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"ref24","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1016\/S2352-3018(17)30065-6","article-title":"Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial","volume":"4","author":"NI Paton","year":"2017","journal-title":"Lancet HIV"},{"issue":"46","key":"ref25","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.15585\/mmwr.mm6446a3","article-title":"Scale-up of HIV Viral Load Monitoring\u2014Seven Sub-Saharan African Countries","volume":"64","author":"S Lecher","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref26","unstructured":"Joint United Nations Programme on HIV\/AIDS. Ambitious treatment targets: writing the final chapter of the AIDS epidemic. 2014. http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/JC2670_UNAIDS_Treatment_Targets_en.pdf<\/ext-link>."},{"issue":"49","key":"ref27","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1086\/648444","article-title":"Viremia, Resuppression, and Time to Resistance in Human Immunodeficiency Virus (HIV) Subtype C during First-Line Antiretroviral Therapy in South Africa","author":"CJ Hoffmann","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"17","key":"ref28","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1097\/QAD.0b013e328311d16f","article-title":"Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen","volume":"22","author":"Z Fox","year":"2008","journal-title":"AIDS"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1177\/135965350701200603","article-title":"Transient viral load increases in HIV-infected children in the U.K. and Ireland: what do they mean?","volume":"12","author":"KJ Lee","year":"2007","journal-title":"Antivir Ther"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1002432","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T08:52:53Z","timestamp":1659862373000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1002432"}},"subtitle":[],"editor":[{"given":"Marie-Louise","family":"Newell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,11,14]]},"references-count":29,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1002432","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,14]]}}}